en 
Deutsch 
Española 
Italiano 
Français 
Polski 
Nederlands 
Svenska (Sverige) 
Czech (Čeština) 
PRIMOMED 100 (Methenolone Enanthate)
• CAS number: 303-42-4
• Molecular Weight: 414.64 g/mol
• Formula: C27H42O3
PRIMOMED 100 by DEUS MEDICAL®
PRIMOMED 100 (Methenolone Enanthate)
Overview
PRIMOMED 100 (Methenolone Enanthate) is indicated for the treatment of aplastic anemia, breast cancer, postmenopausal osteoporosis and sarcopenia (the loss of muscle as correlated with aging). Also, the drug is utilized to treat individuals suffering from conditions in which muscle wasting and severe weight loss is a symptom, and as an immunostimulant for individuals fighting infections. PRIMOMED 100 is manufactured as methenolone enanthate 100mg/ml injections that contain 100mg of methenolone enanthate and excipients.
Methenolone Enanthate Mechanism of Action
Methenolone enanthate is an ester of methenolone, the active form of the drug. Methenolone acts on androgen receptors to exert some of its effects. It has moderate anabolic properties and weak androgenic properties. However, it also exerts some of its effect on the bone marrow which makes it suitable for the treatment of anemia. Its mechanism of action does not produce estrogenic side effects.
Methenolone Acetate Dosage
100mg intramuscular injection taken.
Methenolone Enanthate Side effects
Side effects include masculinization in women, acne, increased sexual libido, and changes in voice, reversible hypogonadism.
Methenolone Enanthate Interactions
Betamethasone phosphate ciclesonide, budesonide.
✓ Methenolone Enanthate . . . . 100mg
✓ Excipients . . . . . . . . . . . . . . . . . . . . . q.s
BECOME A PARTNER
We are offering a diverse range of pharmaceutical products, which are available only from an authorized resellers. Our highly-regarded partners are comprised of industry experts who share our values and commitment. Our goal is to strengthen our network of prestigious professionals who strive to deliver great quality products.
We believe that partnerships are essential to drive change, innovation and transformation, and we are committed to ensuring the success of our collaborations.